| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0003 |